SHIKARI® Q-IPI
The Matriks Biotek® Ipilimumab ELISA has been specially developed for the quantitative analysis of Ipilimumab in serum and plasma samples between the Cmin and Cmax range of concentrations (indicated
in the pharmacokinetics section of protocol linked below).
SHIKARI® S-ATI
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life
10ul
70 min
Serum, plasma
96
100ng/mL
85-115%
1 year
The Matriks Biotek anti-Ipilimumab(Yervoy®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to Ipilimumab(Yervoy®) in serum and plasma. It is for professional use only.
Calibration Curve
SHIKARI® Q-IPI & S-ATI
Ipilimumab (Yervoy®)
Enzyme immunoassay for the quantitative determination of Ipilimumab(Yervoy®) in human serum and plasma
Enzyme immunoassay for the qualitative determination of specific antibodies to Ipilimumab(Yervoy®) in human serum and plasma
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life
10ul
140 min
Serum, plasma
96
+/-
-
1 year
IPI-FD-YER: $1000.00 Lead time: 1-2 weeks
IPI-QLS-YER: $945.00 Lead time: 1-2 weeks
 | ||||
.....................................................
.....................................................
Drug Measurement
Anti-drug Antibody Measurement
Quantitative
Qualitative
Ipilimumab (Yervoy®)
PD-1, PD-L1 and CTLA-4
Iwai North America Inc.
541 Taylor Way Suite# 4
San Carlos, CA 94070
Phone : (650) 486-1541
Fax : (650) 394-8638
Open weekdays 9 AM-6 PM (PST)
.........................................................................................................................................................................................................................................................
